Pavell Jeff
Hoth Therapeutics, Inc. · Director
Pavell Jeff is listed in filings as Director at Hoth Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 28, 2026, including 3 public disclosures. Recent filings connect the profile to Hoth Therapeutics, Inc. (RKTO) and Silo Pharma, Inc. (SILO). The current snapshot covers public activity from Aug 21, 2024 to May 28, 2026. Reported amounts are shown as $53.1K to $18.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||